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Background
Adaptive designs (ADs) are innovative alternative trial
designs with the potential to improve efficiency in clini-
cal trials research when used appropriately. Despite this,
their implementation has been slow to gain traction.
This study explored barriers, concerns and potential
facilitators to appropriate use of ADs in confirmatory
trials.
Methods
Based upon themes drawn from in-depth interviews of
key research stakeholders, we undertook cross-sectional,
online surveys (November 2014 to January 2015) of;
CTUs, public funders and industry in the UK. Observed
response rates were: 55% (30/55) CTUs, 68% (17/25)
industry, and 41% (86/212) public funders. We employed
Rating Scale Modelling [5] to rank the perceived impor-
tance of barriers and concerns for prioritisation.
Results
Most important perceived barriers to adoption in the
public sector included: the lack of bridge funding to
support design developmental work of time consuming
ADs, dearth of practical knowledge and experience, lack
of applied training to facilitate practical learning, prefer-
ence for traditional designs, time constraints to support
planning, insufficient access to case studies, difficulties
in marketing ADs to key research stakeholders and asso-
ciated practical complexities.
Respondents’ perceptions of ADs were consistent
across industry. The exceptions, including bridge fund-
ing support, inadequate data management infrastructure
and regulatory fear, were probably reflections of differ-
ential organisational structures, experience, and type of
research interventions.
Conclusions
There are multifaceted barriers and concerns to the appro-
priate use of ADs most of which are intertwined with lack
of practical knowledge and experience. Learning from
“pacesetters” through applied training and accessible pub-
lication of ADs undertaken coupled with adequate trans-
parent reporting is paramount. There is an urgent need
for a practical toolkit of design specific questions research-
ers need to ask themselves when considering planning
particular ADs and a consensus guidance document on
ADs tailored for publicly funded confirmatory trials.
Authors’ details
1University of Sheffield, School of Health and Related Research, Sheffield, UK.
2University of Reading, Department of Mathematics and Statistics, Reading,
UK.
Published: 16 November 2015
doi:10.1186/1745-6215-16-S2-O20
Cite this article as: Dimairo et al.: Meandering journey towards routine
trial adaptation: survey results on barriers to use of adaptive designs in
confirmatory trials. Trials 2015 16(Suppl 2):O20.
1University of Sheffield, School of Health and Related Research, Sheffield, UK
Full list of author information is available at the end of the article
Dimairo et al. Trials 2015, 16(Suppl 2):O20
http://www.trialsjournal.com/content/16/S2/O20 TRIALS
© 2015 Dimairo et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
